Here are four pricing and frequency trends Arcadia identified.
- Fifty-four percent of drugs measured became more expensive and less common. Examples of drugs in this bracket are Remicade and Hydrocodone.
- Ten percent of drugs measured became more expensive and more common. Examples of drugs in this bracket are Xarelto and Xelijanz.
- Thirty-two percent of drugs measured became less expensive and less common. Examples of drugs in this bracket are Zyprexa and Pariet.
- Four percent of drugs measured became less expensive and more common. Examples of drugs in this bracket are Lipitor and Levaquin.
The access the full report and Arcadia’s drug resource, click here.
More articles on supply chain:
Novo Nordisk defends insulin costs after US Senators allege pricing collusion
Logistics industry adds 7,500 jobs in October: 4 things to know
Safety-net hospitals call for federal investigation into alleged EpiPen overcharges
